Highly mutated memory cells drive an inefficient secondary antibody response to a variant protein
Richard K Tennant, Barbara Holzer, John Love, Elma Tchilian, Harry N WhiteiD
Abstract
A powerful vaccine against mutable viruses might induce memory antibodies that either strongly bound antigenic variants or that could rapidly undergo secondary affinity maturation to achieve this. We have recently shown after secondary immunization of mice with a widely variant protein (Burton et al. 2018) that IgM+ memory B-cells with few mutations supported an efficient secondary germinal centre (GC) and serum response, superior to a primary response to the same protein. Here, boosting with more closely related proteins produced a GC response dominated by highly mutated B-cells that failed, not efficiently improving serum avidity even in the presence of extra adjuvant, and that was worse than a primary response. This supports a hypothesis that over certain antigenic differences, a cross reactive, mutated, memory B-cell compartment can be an impediment to affinity maturation.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid hypermutation B cell trajectory recruits previously primed B cells upon third SARS-CoV-2 mRNA vaccination
L. Paschold, B. Klee, … M. Binder·bioRxiv·Mar 1, 2022
- Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation
- Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
R. Marzi, J. Bassi, … L. Piccoli·bioRxiv·Sep 30, 2022
- Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
L. Yang, M. Van Beek, … A. K. Chakraborty·bioRxiv·Aug 24, 2022
- Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
G. E. Hartley, E. S. J. Edwards, … M. C. van Zelm·bioRxiv·Aug 3, 2022
- Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant.
S. Mise-Omata, M. Ikeda, … A. Yoshimura·bioRxiv·Jul 31, 2022